II
ZVRA icon

Inspire Investing’s Zevra Therapeutics ZVRA Stock Holding History

Inspire Investing’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
+173,016
New +$1.92M 0.1% 228

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inspire Investing's ZVRA Position: Q2 2026 in Review

Inspire Investing opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 173,016 shares worth $2.48M. The stake represents 0.1% of the portfolio and ranks #228 among its holdings.

157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Inspire Investing held 173,016 shares of Zevra Therapeutics worth $2.48M as of Q2 2026.
  • Zevra Therapeutics was a new Inspire Investing position in Q2 2026.
  • Zevra Therapeutics made up 0.1% of Inspire Investing's portfolio in Q2 2026, its #228 holding.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.